These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 16184188

  • 1. Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.
    Pym LJ, Cook SM, Rosahl T, McKernan RM, Atack JR.
    Br J Pharmacol; 2005 Nov; 146(6):817-25. PubMed ID: 16184188
    [Abstract] [Full Text] [Related]

  • 2. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
    Atack JR, Alder L, Cook SM, Smith AJ, McKernan RM.
    Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
    [Abstract] [Full Text] [Related]

  • 3. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
    Turner DM, Sapp DW, Olsen RW.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1236-42. PubMed ID: 1646328
    [Abstract] [Full Text] [Related]

  • 4. Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine.
    Morris HV, Dawson GR, Reynolds DS, Atack JR, Rosahl TW, Stephens DN.
    Pharmacol Biochem Behav; 2008 Jul; 90(1):9-18. PubMed ID: 18358520
    [Abstract] [Full Text] [Related]

  • 5. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors.
    Atack JR, Smith AJ, Emms F, McKernan RM.
    Neuropsychopharmacology; 1999 Mar; 20(3):255-62. PubMed ID: 10063485
    [Abstract] [Full Text] [Related]

  • 6. GABA(A) receptors containing the alpha4-subunit: prevalence, distribution, pharmacology, and subunit architecture in situ.
    Benke D, Michel C, Mohler H.
    J Neurochem; 1997 Aug; 69(2):806-14. PubMed ID: 9231742
    [Abstract] [Full Text] [Related]

  • 7. Does ethanol act preferentially via selected brain GABAA receptor subtypes? the current evidence is ambiguous.
    Korpi ER, Debus F, Linden AM, Malécot C, Leppä E, Vekovischeva O, Rabe H, Böhme I, Aller MI, Wisden W, Lüddens H.
    Alcohol; 2007 May; 41(3):163-76. PubMed ID: 17591542
    [Abstract] [Full Text] [Related]

  • 8. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P, Ducić I, Puia G, Arban R, Walser A, Guidotti A, Costa E.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [Abstract] [Full Text] [Related]

  • 9. Cerebellar GABAA receptors and alcohol-related behaviors: focus on diazepam-insensitive [3H]Ro 15-4513 binding.
    Korpi ER, Uusi-Oukari M.
    Adv Biochem Psychopharmacol; 1992 Aug; 47():289-99. PubMed ID: 1324578
    [No Abstract] [Full Text] [Related]

  • 10. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated.
    Atack JR, Bayley PJ, Fletcher SR, McKernan RM, Wafford KA, Dawson GR.
    Eur J Pharmacol; 2006 Oct 24; 548(1-3):77-82. PubMed ID: 16962577
    [Abstract] [Full Text] [Related]

  • 11. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A, Cook SM, Watt AP, Scott-Stevens P, Rosahl TW, McKernan RM, Pym LJ, Guiblin A, Moyes C, Sohal B, Atack JR.
    Biopharm Drug Dispos; 2007 Sep 24; 28(6):275-82. PubMed ID: 17570124
    [Abstract] [Full Text] [Related]

  • 12. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL, Guscott MR, Bull S, Hallett DJ, Goodacre SC, Wafford KA, Garrett EM, Newman RJ, O'Meara GF, Whiting PJ, Rosahl TW, Dawson GR, Reynolds DS, Atack JR.
    J Psychopharmacol; 2007 Jun 24; 21(4):384-91. PubMed ID: 17092983
    [Abstract] [Full Text] [Related]

  • 13. Investigation of the abundance and subunit composition of GABAA receptor subtypes in the cerebellum of alpha1-subunit-deficient mice.
    Ogris W, Lehner R, Fuchs K, Furtmüller B, Höger H, Homanics GE, Sieghart W.
    J Neurochem; 2006 Jan 24; 96(1):136-47. PubMed ID: 16277610
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.
    Liu R, Hu RJ, Zhang P, Skolnick P, Cook JM.
    J Med Chem; 1996 Apr 26; 39(9):1928-34. PubMed ID: 8627617
    [Abstract] [Full Text] [Related]

  • 15. Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands.
    Kelly MD, Smith A, Banks G, Wingrove P, Whiting PW, Atack J, Seabrook GR, Maubach KA.
    Br J Pharmacol; 2002 Jan 26; 135(1):248-56. PubMed ID: 11786501
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute administration of alcohol on in vivo binding of [3H]Ro 15-1788 to mouse brain.
    Mosaddeghi M, Burke TF, Moerschbaecher JM.
    J Pharmacol Exp Ther; 1992 Nov 26; 263(2):639-45. PubMed ID: 1331409
    [Abstract] [Full Text] [Related]

  • 17. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment.
    Smith TA.
    Br J Biomed Sci; 2001 Nov 26; 58(2):111-21. PubMed ID: 11440203
    [Abstract] [Full Text] [Related]

  • 18. Ro 15-4513 binding to GABAA receptors: subunit composition determines ligand efficacy.
    Wong G, Skolnick P.
    Pharmacol Biochem Behav; 1992 May 26; 42(1):107-10. PubMed ID: 1326771
    [Abstract] [Full Text] [Related]

  • 19. Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor.
    Korpi ER, Kleingoor C, Kettenmann H, Seeburg PH.
    Nature; 1993 Jan 28; 361(6410):356-9. PubMed ID: 7678923
    [Abstract] [Full Text] [Related]

  • 20. Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines.
    Mäkelä R, Uusi-Oukari M, Homanics GE, Quinlan JJ, Firestone LL, Wisden W, Korpi ER.
    Mol Pharmacol; 1997 Sep 28; 52(3):380-8. PubMed ID: 9281599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.